openPR Logo
Press release

Coronary Stents Market Size to Boost USD 12.83 Billion By 2032 | CAGR 3.3% - Published by Emergen Research

04-23-2024 07:29 AM CET | Health & Medicine

Press release from: Emergen Research

Coronary Stents Market

Coronary Stents Market

The global Coronary Stents Market size was USD 9.32 Billion in 2022 and is expected to register a rapid revenue CAGR of 3.3% during the forecast period. Increasing prevalence of Cardiovascular Diseases (CVDs), such as heart disease and stroke, and technological advancements in coronary stents are key factors driving market revenue growth.

The coronary stents market is a crucial segment within the broader cardiovascular medical devices industry, playing a pivotal role in the treatment of coronary artery disease (CAD) and other cardiovascular conditions. Coronary stents are small, mesh-like tubes inserted into narrowed or blocked coronary arteries to restore blood flow, alleviate symptoms, and prevent complications such as heart attacks. This market is characterized by dynamic growth driven by various factors and influenced by both opportunities and challenges.

 The report offers these individuals a vivid description of the competitive spectrum of the global Coronary Stents Market The study audits various winning strategies adopted by the market leaders to maintain the competitive edge worldwide. This adds more clarity to the research. Resource charts, tables and graphical images are included to make decisive statistics self-explanatory.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2774

Drivers of the Coronary Stents Market :

One of the primary drivers propelling the coronary stents market forward is the increasing prevalence of cardiovascular diseases globally. Factors such as sedentary lifestyles, unhealthy dietary habits, and rising rates of obesity contribute to the growing burden of CAD and related conditions, driving the demand for interventional cardiology procedures, including stent implantation. Moreover, advancements in stent technology, including the development of drug-eluting stents (DES) and bioresorbable stents, have significantly improved treatment outcomes, reducing the risk of restenosis and thrombosis and expanding the market's potential.

Challenges and Restraints

Despite the positive growth trajectory, the coronary stents market faces several challenges and restraints. One significant challenge is the stringent regulatory approval process for new stent technologies, which can delay market entry and increase development costs for manufacturers. Moreover, concerns about the long-term safety and efficacy of certain types of stents, particularly drug-eluting stents, have led to debates and regulatory scrutiny, impacting market dynamics and adoption rates.

 Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2774

The report also discusses the key players involved in the market such as:

Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Johnson & Johnson, B. Braun Melsungen AG, C. R. Bard, BIOTRONIK SE & Co. KG, Cook Medical, MicroPort Scientific Corporation, Meril Life Sciences, Vascular Concepts, Stentys SA, Elixir Medical Corporation, Translumina GmbH, Sinomed, Hexacath, Alvimedica, Biotronik SE & Co. KG, and Kyoto Medical Planning Co., Ltd.

The report provides a thorough estimation of the overall impact of the pandemic on the Coronary Stents Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Coronary Stents Market

Coronary Stents Latest Industry Updates

On 25 August, 2022, Medtronic launched its Onyx Frontier drug-eluting coronary stent, enhancing its product line after receiving CE mark approval. The stent, designed for coronary artery disease treatment, features an enhanced delivery system, a dual-layer balloon, and increased catheter flexibility, improving deliverability by 16%. The design changes, inherited from Resolute Onyx drug-eluting stent, aim to provide acute performance and clinical benefits. With recent CE mark approval and prior FDA approval, Medtronic plans to offer Onyx Frontier in western Europe and globally, reinforcing the company's commitment to interventional cardiology innovation.

On 19 October, 2020, Biosensors obtained the CE Mark for its BioFreedomUltra drug-coated coronary stent system. The thin-strut CoCr polymer stent, incorporating the Biolimus A9 drug, aims to optimize percutaneous coronary intervention procedures for High Bleeding Risk (HBR) patients. The Leaders Free III trial demonstrated non-inferior safety and superior efficacy of BioFreedom Ultra compared to the Drug-Coated Stainless Steel Stent (DCS-StS) and Bare Metal Stent (BMS) groups. The stent's design simplifies pre-procedure stent choice, enhancing success rates and maximizing outcomes for HBR patients treated with a one-month dual antiplatelet therapy

 Direct Order Can Be Placed Through This Link [Exclusive Copy] @  https://www.emergenresearch.com/select-license/2774

Coronary Stents Market Segment Analysis :

For the purpose of this report, Emergen Research has segmented the global coronary stents market on the basis of type, application, deployment, enterprise size, component, vertical, and region:

Product Type Outlook (Revenue, USD Billion; 2019-2032)
Drug-Eluting Stents (DES)
Bare Metal Stents (BMS)
Bioresorbable Stents
Material Outlook (Revenue, USD Billion; 2019-2032)
Metal Stents:
Stainless Steel
Cobalt-Chromium
Platinum-Chromium
Nickel-Titanium (Nitinol)
Polymer Stents:
Bioresorbable Polymers
Non-bioresorbable Polymers
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Ambulatory Surgical Centers (ASCs)
Cardiac Catheterization Laboratories
Application Outlook (Revenue, USD Billion; 2019-2032)
Coronary Artery Diseases
Acute Coronary Syndrome (ACS)
Technology (Revenue, USD Billion; 2019-2032)
Balloon Expandable Stents
Self-Expandable Stents
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa

 Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/coronary-stents-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronary Stents Market Size to Boost USD 12.83 Billion By 2032 | CAGR 3.3% - Published by Emergen Research here

News-ID: 3472666 • Views:

More Releases from Emergen Research

Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Publi …
The global Bacteriophage Market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth. Bacteriophages have been shown to be
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | CAGR 23.6% - Published by Emergen Research
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 2032 | CAGR 13.9% - Published by Emergen Research
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - Published by Emergen Research
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion

All 5 Releases


More Releases for Stent

Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still